Siirry sisältöön

Seegene Allplex SARS-CoV-2 coronavirus tests

Full screening and identification of the virus and its variants

Seegene has effective testing solution to mitigate the spread of rapidly mutating COVID-19 and variants. Seegene’s Allplex™ Assays are based on multiplex real-time PCR with high sensitivity and specificity by utilization of Seegene’s proprietary technologies.

Get the best combination

Allplex™ SARS-CoV-2 Assay is CE-IVD-marked real time multiplex-PCR assay. It detects coronavirus (SARS-CoV-2) based on the spesific target genes. Several different assays to detect both SARS-CoV-2 and its variants are available to cover the needs. The assays are under continous development to be able to detect the newest variants.

Only for prosessional use.

COVID-19 or not?

  • Targets: N gene, S gene, RdRP gene, E gene

SARS-CoV-2 or a variant?

  • Targets: E gene, N gene, RdRP/S gene, HV 69/70 deletion, N501Y, E484K, Y144 deletion and P681H in S gene

Which SARS-CoV-2 variants?

  • Targets: RdRP gene, E484K in S gene, N501Y in S gene, HV69/70 deletion in S gene / L425R in S gene, W152C in S gene, K417N in S gene, K417T in S gene

SARS-CoV-2 of Flu?

  • Targets: N gene, S gene, RdRP gene, Influenza A, Influenza B, RSV A/B

Results in 30 minutes, no pretreatment needed

  • Targets: SARS-CoV-2 (N gene, RdRP gene)

Manufacturer’s product page

Product is available in the following countries:

  • Finland